← Open Payments lookup

ETHAN MYTINGER: Open Payments

NPI 1932753100 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$10,315 in 231 payments from 23 companies in 2025. Trend: 2023 $2,659 · 2024 $5,590 · 2025 $10,315

Food & beverage: $6,815Consulting: $3,450Education: $51
CompanyPaymentsAmount
Amgen Inc.1$2,400
Janssen Biotech, Inc.21$2,012
ABBVIE INC.55$1,348
Gilead Sciences, Inc.22$772
GENZYME CORPORATION9$430
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$426
Madrigal Pharmaceuticals10$402
Takeda Pharmaceuticals U.S.A., Inc.14$387
Lilly USA, LLC9$293
Ipsen Biopharmaceuticals, Inc10$292

Products named: BLINCYTO, TREMFYA, SKYRIZI, DUPIXENT, XIFAXAN, REZDIFFRA, ENTYVIO, OMVOH.

Industry payments across CO — which companies pay providers there.